Finch Therapeutics falls on 1-for-30 reverse stock split

Finch Therapeutics

09/06/2023 14:56

** Drug developer Finch Therapeutics Group Inc's  FNCH.O 
shares down 5.3% at $0.27 
    ** Company says it will effect a 1-for-30 reverse stock
split of its issued and outstanding common stock
    ** Company expects upon opening of trading on June 12,
common stock will trade on Nasdaq on split-adjusted basis
    ** As of Thursday's close, stock down ~40% YTD

 (Reporting by Amna Karimi in Bengaluru)
 ((Amna.Karimi@thomsonreuters.com; +91 8083261226))